News

The Multiple Myeloma Research Foundation (MMRF) Launches MyDRUG — First-ever Platform Clinical Trial in Multiple Myeloma

The Multiple Myeloma Research Foundation (MMRF) announced today that it is launching MyDRUG, the first platform trial exclusively in multiple myeloma, which aims to investigate targeted treatments for high-risk myeloma patients. MyDRUG represents the culmination of the MMRF’s Precision Medicine Model, the only end-to-end model of its type in cancer.

READ FULL ARTICLE ON URLDEFENSE.PROOFPOINT.COM